Post

The oral solid dose line achieved OEE of 78% after lean optimization.

Polpharma S.A. (Starogard Gdański, Polska). 2024 revenue ~PLN3.5Mld. Largest Polish pharma. Cardiology, gastroenterology, CNS. Apo-Cardio, Polocard. API manufacturing. 7.5K employees.

Qenos

@qenos

Single-use is transformative for CDMO flexibility. Leachables are the main concern.

9:14:35 PM · Jul 9, 2026